Evertis selects Honeywell Aclar technology for pharmaceutical packaging

Honeywell Aclar film technology will enable Evertis to develop barrier packaging solutions.

medical waste

karichs | stock.adobe.com

Honeywell, headquartered in Charlotte, North Carolina, has announced that Evertis, a Portuguese producer of film for packaging, has selected Honeywell Aclar film to be used by its Evercare pharmaceutical brand.

Honeywell Aclar film is a medical-grade material that can be used for both rigid and flexible packaging solutions. According to Honeywell, the material helps protect the efficacy of prescription and over-the-counter (OTC) medication by providing the best-available moisture barrier polymer for drug stability. The film can help extend shelf life and reduce waste in the pharmaceutical industry, according to Honeywell.

Further, the company says, unique technical production methods make it easy to separate and recycle Aclar films, supporting the industry’s efforts to shift toward recyclable solutions.

Through its Evercare brand, Evertis will use Aclar to develop medical-grade polyethylene terephthalate (PET) packaging materials. PET packaging is widely used in various industries because of its lightweight and versatile nature, the companies say. According to Honeywell, by using Aclar films in PET packaging, Evertis can optimize manufacturing processes, reduce production costs and provide new packaging options for the industry.

“We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging,” says Casimiro Sacchetti, chief sales officer for Evertis Americas. “By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing and optical properties—while also meeting sustainability credentials.”

Honeywell says it will work with Evertis to help support the design, development and launch of new packaging materials.

“Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in health care,” says Jeff Dormo, president of sustainability and decarbonization at Honeywell Energy and Sustainability Solutions. “Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”

The PET products are expected to be on the market this year.